Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design

被引：1
|
作者：
Alvarez, Ricardo H. [1 ]
Hortobagyi, Gabriel N. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2010年 / 124卷 / 03期
关键词：
SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL RESPONSE; INDUCTION CHEMOTHERAPY; PREDICTIVE MARKERS; DOXORUBICIN; SURVIVAL; WOMEN; CYCLOPHOSPHAMIDE;
D O I：
10.1007/s10549-010-1212-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：701 / 705
页数：5
相关论文
共 50 条
  • [41] Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study
    Ueno, Takayuki
    Masuda, Norikazu
    Sato, Nobuaki
    Ohtani, Shoichiro
    Yamamura, Jun
    Matsunami, Nobuki
    Kashiwaba, Masahiro
    Takano, Toshimi
    Takahashi, Masato
    Kaneko, Koji
    Ohno, Shinji
    Morita, Satoshi
    Toi, Masakazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (01) : 3 - 11
  • [42] Evaluation of Breast and Axillary Lymph Node Specimens in Breast Cancer Patients Treated With Neoadjuvant Systemic Therapy
    Baker, Gabrielle M.
    King, Tari A.
    Schnitt, Stuart J.
    ADVANCES IN ANATOMIC PATHOLOGY, 2019, 26 (04) : 221 - 234
  • [43] Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer
    Ganem, G
    Tubiana-Hulin, M
    Fumoleau, P
    Combe, M
    Misset, JL
    Vannetzel, JM
    Bachelot, T
    De Ybarlucea, LR
    Lotz, V
    Bendahmane, B
    Dieras, V
    ANNALS OF ONCOLOGY, 2003, 14 (11) : 1623 - 1628
  • [44] Concurrent administration of chemo-endocrine therapy for postmenopausal breast cancer patients
    Watanabe, Naoki
    Ootawa, Yasuyuki
    Kodama, Kikue
    Kaide, Akemi
    Ootsuka, Nobutoshi
    Matsuoka, Jyunji
    BREAST CANCER, 2010, 17 (04) : 247 - 253
  • [45] Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer: A Secondary Analysis of the GeparTrio Trial Data
    Costa, Serban Dan
    Loibl, Sibylle
    Kaufmann, Manfred
    Zahm, Dirk-Michael
    Hilfrich, Joern
    Huober, Jens
    Eidtmann, Holger
    du Bois, Andreas
    Blohmer, Jens-Uwe
    Ataseven, Beyhan
    Weiss, Erich
    Tesch, Hans
    Gerber, Bernd
    Baumann, Klaus H.
    Thomssen, Christoph
    Breitbach, Georg Peter
    Ibishi, Shaip
    Jackisch, Christian
    Mehta, Keyur
    von Minckwitz, Gunter
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 83 - 91
  • [46] Preoperative Chemotherapy for Operable Breast Cancer Is Associated with Better Compliance with Adjuvant Therapy in Matched Stage II and IIIA Patients
    Komenaka, Ian K.
    Hsu, Chiu-Hsieh
    Martinez, Maria Elena
    Bouton, Marcia E.
    Low, Boo Ghee
    Salganick, Jason A.
    Nodora, Jesse
    Hibbard, Michael L.
    Jha, Chandra
    ONCOLOGIST, 2011, 16 (06) : 742 - 751
  • [47] Systemic therapy for early breast cancer in older adults: current status and prospects
    Battisti, Nicolo Matteo Luca
    Biganzoli, Laura
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (06) : 574 - 583
  • [48] Selective sentinel lymph node biopsy and primary systemic therapy in breast cancer
    Pinero, Antonio
    Gimenez, Julia
    Vidal-Sicart, Sergi
    Intra, Mattia
    TUMORI JOURNAL, 2010, 96 (01): : 17 - 23
  • [49] Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer.
    Kuroi K.
    Toi M.
    Tsuda H.
    Kurosumi M.
    Akiyama F.
    Breast Cancer, 2006, 13 (1) : 38 - 48
  • [50] Phase II Trial of Dose Dense Docetaxel Followed by FEC100 as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer
    Jacot, William
    Bibeau, Frederic
    Gourgou-Bourgade, Sophie
    Gutowski, Marian
    Colombo, Pierre-Emmanuel
    Bleuse, Jean-Pierre
    Kramar, Andrew
    Romieu, Gilles
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 544 - 549
12345